Molecular Mechanisms of <i<Cassia fistula</i< against Epithelial Ovarian Cancer Using Network Pharmacology and Molecular Docking Approaches

Epithelial ovarian cancer (EOC) is one of the deadliest reproductive tract malignancies that form on the external tissue covering of an ovary. <i<Cassia fistula</i< is popular for its anti-inflammatory and anticarcinogenic properties in conventional medications. Nevertheless, its molecul...
Ausführliche Beschreibung

Epithelial ovarian cancer (EOC) is one of the deadliest reproductive tract malignancies that form on the external tissue covering of an ovary. <i<Cassia fistula</i< is popular for its anti-inflammatory and anticarcinogenic properties in conventional medications. Nevertheless, its molecular mechanisms are still unclear. The current study evaluated the potential of <i<C. fistula</i< for the treatment of EOC using network pharmacology approach integrated with molecular docking. Eight active constituents of <i<C. fistula</i< were obtained from two independent databases and the literature, and their targets were retrieved from the SwissTargetPrediction. In total, 1077 EOC associated genes were retrieved from DisGeNET and GeneCardsSuite databases, and 800 potential targets of eight active constituents of <i<C. fistula</i< were mapped to the 1077 EOC targets and intersected targets from two databases. Ultimately, 98 potential targets were found from <i<C. fistula</i< for EOC. Finally, the protein–protein interaction network (PPI) topological interpretation revealed AKT1, CTNNB1, ESR1, and CASP3 as key targets. This is the first time four genes have been found against EOC from <i<C. fistula</i<. The major enriched pathways of these candidate genes were established by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) investigations. To confirm the network pharmacology findings, the molecular docking approach demonstrated that active molecules have higher affinity for binding to putative targets for EOC suppression. More pharmacological and clinical research is required for the development of a drug to treat EOC. Ausführliche Beschreibung